Samuel Fanijo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samuel Fanijo has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
Abdul-Hakeem Omotayo
1 shared publication- Abdul-Hakeem Omotayo
Department of Statistics, University of California Davis
1 shared publication Abdulmejid Johar
1 shared publicationAbeeb Afolabi
1 shared publicationAbraham Owodunni
1 shared publication- Adebimpe O. Esan1 shared publication
Latest Publications
- Open Access
- 1 September 2026
- Published by Elsevier in Machine Learning with Applications
- Vol. 25
SCOPE-LM: Single Cell Context-Conditioned and Pathway-Enhanced Language Model for Cell Type Annotation
- 1 September 2026
- Published by Elsevier in Machine Learning with Applications
- Vol. 25
Open AccessSCOPE-LM: Single Cell Context-Conditioned and Pathway-Enhanced Language Model for Cell Type Annotation
- Open Access
- 14 February 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (2) , 184
IDCC-SAM: A Zero-Shot Approach for Cell Counting in Immunocytochemistry Dataset Using the Segment Anything Model
Cell counting in immunocytochemistry is vital for biomedical research, supporting the diagnosis and treatment of diseases such as neurological disorders, autoimmune conditions, and cancer. However, traditional counting methods are manual, time-consuming, and error-prone, while deep learning solutions require costly labeled datasets, limiting scalability. We introduce the Immunocytochemistry Dataset Cell Counting with Segment Anything Model (IDCC-SAM), a novel application of the Segment Anything Model (SAM), designed to adapt the model for zero-shot-based cell counting in fluorescent microscopic immunocytochemistry datasets. IDCC-SAM leverages Meta AI’s SAM, pre-trained on 11 million images, to eliminate the need for annotations, enhancing scalability and efficiency. Evaluated on three public datasets (IDCIA, ADC, and VGG), IDCC-SAM achieved the lowest Mean Absolute Error (26, 28, 52) on VGG and ADC and the highest Acceptable Absolute Error (28%, 26%, 33%) across all datasets, outperforming state-of-the-art supervised models like U-Net and Mask R-CNN, as well as zero-shot benchmarks like NP-SAM and SAM4Organoid. These results demonstrate IDCC-SAM’s potential to improve cell-counting accuracy while reducing reliance on specialized models and manual annotations.
- 14 February 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (2) , 184
Open AccessIDCC-SAM: A Zero-Shot Approach for Cell Counting in Immunocytochemistry Dataset Using the Segment Anything Model
Cell counting in immunocytochemistry is vital for biomedical research, supporting the diagnosis and treatment of diseases such as neurological disorders, autoimmune conditions, and cancer. However, traditional counting methods are manual, time-consuming, and error-prone, while deep learning solutions require costly labeled datasets, limiting scalability. We introduce the Immunocytochemistry Dataset Cell Counting with Segment Anything Model (IDCC-SAM), a novel application of the Segment Anything Model (SAM), designed to adapt the model for zero-shot-based cell counting in fluorescent microscopic immunocytochemistry datasets. IDCC-SAM leverages Meta AI’s SAM, pre-trained on 11 million images, to eliminate the need for annotations, enhancing scalability and efficiency. Evaluated on three public datasets (IDCIA, ADC, and VGG), IDCC-SAM achieved the lowest Mean Absolute Error (26, 28, 52) on VGG and ADC and the highest Acceptable Absolute Error (28%, 26%, 33%) across all datasets, outperforming state-of-the-art supervised models like U-Net and Mask R-CNN, as well as zero-shot benchmarks like NP-SAM and SAM4Organoid. These results demonstrate IDCC-SAM’s potential to improve cell-counting accuracy while reducing reliance on specialized models and manual annotations.
- Open Access
- 22 September 2024
- Published by IntSys Research in Journal of Future Artificial Intelligence and Technologies
- Vol. 1 (2) , 143-159
AI4CRC: A Deep Learning Approach Towards Preventing Colorectal Cancer
Each year, more than 1.9 million cases of colorectal cancer (CRC) are diagnosed worldwide. By 2040, the burden of colorectal cancer is estimated to reach 3.2 million new cases per year and 1.6 million deaths per year worldwide. As of 2024, it ranks as the third most prevalent form of cancer, contributing to over 10% of all new cancer cases annually, with a 5-year survival rate of only 65%. With effective early detection mechanisms in place, the survival rate could potentially increase to 90%. However, current detection mechanisms are manual and error-prone. This study presents a deep learning-based approach to automating the detection of polyps, the tumor that causes colorectal cancer, in the human colon. Various state-of-the-art deep learning models – including VGG, ResNet, DenseNet, and EfficientNet were trained and tested on a publicly available dataset. The findings of this study show that deep learning models can significantly automate the early diagnosis process of colorectal cancer with high accuracy, especially the DenseNet and EfficientNet models – attaining 99% and 99.4% respectively for both accuracy and F1 score metrics on the test dataset. This study validates the potential of deep learning to enhance the accuracy and reliability of colorectal cancer detection and prevention, ultimately contributing to better quality of diagnosis and patient outcomes.
- 22 September 2024
- Published by IntSys Research in Journal of Future Artificial Intelligence and Technologies
- Vol. 1 (2) , 143-159
Open AccessAI4CRC: A Deep Learning Approach Towards Preventing Colorectal Cancer
Each year, more than 1.9 million cases of colorectal cancer (CRC) are diagnosed worldwide. By 2040, the burden of colorectal cancer is estimated to reach 3.2 million new cases per year and 1.6 million deaths per year worldwide. As of 2024, it ranks as the third most prevalent form of cancer, contributing to over 10% of all new cancer cases annually, with a 5-year survival rate of only 65%. With effective early detection mechanisms in place, the survival rate could potentially increase to 90%. However, current detection mechanisms are manual and error-prone. This study presents a deep learning-based approach to automating the detection of polyps, the tumor that causes colorectal cancer, in the human colon. Various state-of-the-art deep learning models – including VGG, ResNet, DenseNet, and EfficientNet were trained and tested on a publicly available dataset. The findings of this study show that deep learning models can significantly automate the early diagnosis process of colorectal cancer with high accuracy, especially the DenseNet and EfficientNet models – attaining 99% and 99.4% respectively for both accuracy and F1 score metrics on the test dataset. This study validates the potential of deep learning to enhance the accuracy and reliability of colorectal cancer detection and prevention, ultimately contributing to better quality of diagnosis and patient outcomes.
- Open Access
- 10 July 2024
- Published by Association for Computing Machinery (ACM)
- p. 293-302
CIRAL: A Test Collection for CLIR Evaluations in African Languages
Cross-lingual information retrieval (CLIR) continues to be an actively studied topic in information retrieval (IR), and there have been consistent efforts in curating test collections to support its research. However, there is a lack of high-quality human-annotated CLIR resources for African languages: the few existing collections are mostly curated synthetically or from sources with limited corpora for these languages. We present CIRAL, a test collection for cross-lingual retrieval with English queries and passages in four African languages: Hausa, Somali, Swahili, and Yoruba. CIRAL's corpora are obtained from Indigenous African websites and consist of a total of over 2.5 million passages. We gathered over 1,600 queries and 30k high-quality binary relevance judgments annotated by native speakers of the languages. Additional pools were also obtained at CIRAL's shared task, which was hosted at the Forum for Information Retrieval Evaluation 2023 to encourage community participation in CLIR for African languages. We describe the design and curation process of our test collection and provide reproducible baselines that demonstrate CIRAL's utility in evaluating the effectiveness of systems. CIRAL is available at https://github.com/ciralproject/ciral.
- 10 July 2024
- Published by Association for Computing Machinery (ACM)
- p. 293-302
Open AccessCIRAL: A Test Collection for CLIR Evaluations in African Languages
Cross-lingual information retrieval (CLIR) continues to be an actively studied topic in information retrieval (IR), and there have been consistent efforts in curating test collections to support its research. However, there is a lack of high-quality human-annotated CLIR resources for African languages: the few existing collections are mostly curated synthetically or from sources with limited corpora for these languages. We present CIRAL, a test collection for cross-lingual retrieval with English queries and passages in four African languages: Hausa, Somali, Swahili, and Yoruba. CIRAL's corpora are obtained from Indigenous African websites and consist of a total of over 2.5 million passages. We gathered over 1,600 queries and 30k high-quality binary relevance judgments annotated by native speakers of the languages. Additional pools were also obtained at CIRAL's shared task, which was hosted at the Forum for Information Retrieval Evaluation 2023 to encourage community participation in CLIR for African languages. We describe the design and curation process of our test collection and provide reproducible baselines that demonstrate CIRAL's utility in evaluating the effectiveness of systems. CIRAL is available at https://github.com/ciralproject/ciral.
- 17 June 2024
- Published by Iowa State University
IDCC-SAM: Automated cell counting in immunocytochemistry using the segment anything model
Cell counting in Immunocytochemistry is crucial for biomedical research, aiding the diagnosis and treatment of several diseases such as neurological disorders, autoimmune disorders, and cancer. However, traditional counting methods are manual, time-consuming, and prone to human error. While deep learning methods have improved this problem, they rely on labeled datasets, which are also expensive to obtain, posing challenges for scalability and efficiency. In this work, we present the Immunocytochemistry Dataset Cell Counting using the Segment Anything Model (IDCC-SAM), a pipeline that leverages a zero-shot approach to segment and count cells in immunocytochemistry cellular images using SAM under unprompted settings with no required manual labels. IDCC-SAM utilizes the Meta AI’s Segment Anything Model (SAM), pre-trained on 11 million images and 1.1billion masks, to segment and count cells in Immunocytochemistry cellular images. By employing a zero-shot approach, IDCC-SAM eliminates the need for manual annotations, enhancing scalability and reducing menial human labeling effort. Our experimental results demonstrate that IDCC-SAM achieves a new benchmark performance on the IDCIA immunocytochemistry dataset, outperforming the traditional supervised state-of-the-art Mask RCNN model by 9% and UNet by 1%, despite the latter being fine-tuned on labeled examples. Our work shows evidence that SAM has the potential to improve performance on cell counting tasks while reducing the reliance on specialized models and manual annotation efforts, via a zero-shot approach.
- 17 June 2024
- Published by Iowa State University
IDCC-SAM: Automated cell counting in immunocytochemistry using the segment anything model
Cell counting in Immunocytochemistry is crucial for biomedical research, aiding the diagnosis and treatment of several diseases such as neurological disorders, autoimmune disorders, and cancer. However, traditional counting methods are manual, time-consuming, and prone to human error. While deep learning methods have improved this problem, they rely on labeled datasets, which are also expensive to obtain, posing challenges for scalability and efficiency. In this work, we present the Immunocytochemistry Dataset Cell Counting using the Segment Anything Model (IDCC-SAM), a pipeline that leverages a zero-shot approach to segment and count cells in immunocytochemistry cellular images using SAM under unprompted settings with no required manual labels. IDCC-SAM utilizes the Meta AI’s Segment Anything Model (SAM), pre-trained on 11 million images and 1.1billion masks, to segment and count cells in Immunocytochemistry cellular images. By employing a zero-shot approach, IDCC-SAM eliminates the need for manual annotations, enhancing scalability and reducing menial human labeling effort. Our experimental results demonstrate that IDCC-SAM achieves a new benchmark performance on the IDCIA immunocytochemistry dataset, outperforming the traditional supervised state-of-the-art Mask RCNN model by 9% and UNet by 1%, despite the latter being fine-tuned on labeled examples. Our work shows evidence that SAM has the potential to improve performance on cell counting tasks while reducing the reliance on specialized models and manual annotation efforts, via a zero-shot approach.
- Open Access
- 30 August 2023
- Published by GSC Online Press in World Journal of Advanced Research and Reviews
- Vol. 19 (2) , 1578-1587
Artificial intelligence-powered analysis of medical images for early detection of neurodegenerative diseases
Neurodegenerative diseases including Alzheimer's, Parkinson's, and Huntington's offer serious health issues to people all over the world, due to their progressive nature and lack of effective therapies. In order to improve patient outcomes and allow for prompt action to limit the progression of the disease, early identification is essential. With a focus on deep learning methods, this study investigates the use of AI-powered analysis of medical images for the early detection of neurodegenerative disorders. The use of several medical imaging modalities, such as PET, CT, and MRI, in identifying disease biomarkers at an early stage is investigated. The usefulness of deep learning techniques to automate feature extraction, categorize illness states, and track disease progression is highlighted. These techniques include convolutional neural networks [CNNs], recurrent neural networks [RNNs], and generative adversarial networks [GANs]. The study also discusses the difficulties in using AI implementation, including data quality, image variability, and the interpretability of AI models. Furthermore, the study explores possible regulatory and ethical considerations in clinical adoption. It also examines AI's growing role in clinical settings and its ability to work with personalized medicine which present promising opportunities for improving the diagnosis and management neurodegenerative disease. The final section of this paper outlines important future directions for increasing the use of AI in clinical care, including multi-modal fusion and transfer learning.
- 30 August 2023
- Published by GSC Online Press in World Journal of Advanced Research and Reviews
- Vol. 19 (2) , 1578-1587
Open AccessArtificial intelligence-powered analysis of medical images for early detection of neurodegenerative diseases
Neurodegenerative diseases including Alzheimer's, Parkinson's, and Huntington's offer serious health issues to people all over the world, due to their progressive nature and lack of effective therapies. In order to improve patient outcomes and allow for prompt action to limit the progression of the disease, early identification is essential. With a focus on deep learning methods, this study investigates the use of AI-powered analysis of medical images for the early detection of neurodegenerative disorders. The use of several medical imaging modalities, such as PET, CT, and MRI, in identifying disease biomarkers at an early stage is investigated. The usefulness of deep learning techniques to automate feature extraction, categorize illness states, and track disease progression is highlighted. These techniques include convolutional neural networks [CNNs], recurrent neural networks [RNNs], and generative adversarial networks [GANs]. The study also discusses the difficulties in using AI implementation, including data quality, image variability, and the interpretability of AI models. Furthermore, the study explores possible regulatory and ethical considerations in clinical adoption. It also examines AI's growing role in clinical settings and its ability to work with personalized medicine which present promising opportunities for improving the diagnosis and management neurodegenerative disease. The final section of this paper outlines important future directions for increasing the use of AI in clinical care, including multi-modal fusion and transfer learning.
- Top Cited PapersOpen Access
- 1 January 2023
- Published by Association for Computational Linguistics (ACL)
- p. 144-159
MasakhaNEWS: News Topic Classification for African languages
David Ifeoluwa Adelani, Marek Masiak, Israel Abebe Azime, Jesujoba Alabi, Atnafu Lambebo Tonja, Christine Mwase, Odunayo Ogundepo, Bonaventure F. P. Dossou, Akintunde Oladipo, Doreen Nixdorf, Chris Chinenye Emezue, Sana Al-azzawi, Blessing Sibanda, Davis David, Lolwethu Ndolela, Jonathan Mukiibi, Tunde Ajayi, Tatiana Moteu, Brian Odhiambo, Abraham Owodunni, Nnaemeka Obiefuna, Muhidin Mohamed, Shamsuddeen Hassan Muhammad, Teshome Mulugeta Ababu, Saheed Abdullahi Salahudeen, Mesay Gemeda Yigezu, Tajuddeen Gwadabe, Idris Abdulmumin, Mahlet Taye, Oluwabusayo Awoyomi, Iyanuoluwa Shode, Tolulope Adelani, Habiba Abdulganiyu, Abdul-Hakeem Omotayo, Adetola Adeeko, Abeeb Afolabi, Anuoluwapo Aremu, Olanrewaju Samuel, Clemencia Siro, Wangari Kimotho, Onyekachi Ogbu, Chinedu Mbonu, Chiamaka Chukwuneke, Samuel Fanijo, Jessica Ojo, Oyinkansola Awosan, Tadesse Kebede, Toadoum Sari Sakayo, Pamela Nyatsine, Freedmore Sidume, Oreen Yousuf, Mardiyyah Oduwole, Kanda Tshinu, Ussen Kimanuka, Thina Diko, Siyanda Nxakama, Sinodos Nigusse, Abdulmejid Johar, Shafie Mohamed, Fuad Mire Hassan, Moges Ahmed Mehamed, Evrard Ngabire, Jules Jules, Ivan Ssenkungu, Pontus Stenetorp. Proceedings of the 13th International Joint Conference on Natural Language Processing and the 3rd Conference of the Asia-Pacific Chapter of the Association for Computational Linguistics (Volume 1: Long Papers). 2023.
- 1 January 2023
- Published by Association for Computational Linguistics (ACL)
- p. 144-159
Top Cited PapersOpen AccessMasakhaNEWS: News Topic Classification for African languages
David Ifeoluwa Adelani, Marek Masiak, Israel Abebe Azime, Jesujoba Alabi, Atnafu Lambebo Tonja, Christine Mwase, Odunayo Ogundepo, Bonaventure F. P. Dossou, Akintunde Oladipo, Doreen Nixdorf, Chris Chinenye Emezue, Sana Al-azzawi, Blessing Sibanda, Davis David, Lolwethu Ndolela, Jonathan Mukiibi, Tunde Ajayi, Tatiana Moteu, Brian Odhiambo, Abraham Owodunni, Nnaemeka Obiefuna, Muhidin Mohamed, Shamsuddeen Hassan Muhammad, Teshome Mulugeta Ababu, Saheed Abdullahi Salahudeen, Mesay Gemeda Yigezu, Tajuddeen Gwadabe, Idris Abdulmumin, Mahlet Taye, Oluwabusayo Awoyomi, Iyanuoluwa Shode, Tolulope Adelani, Habiba Abdulganiyu, Abdul-Hakeem Omotayo, Adetola Adeeko, Abeeb Afolabi, Anuoluwapo Aremu, Olanrewaju Samuel, Clemencia Siro, Wangari Kimotho, Onyekachi Ogbu, Chinedu Mbonu, Chiamaka Chukwuneke, Samuel Fanijo, Jessica Ojo, Oyinkansola Awosan, Tadesse Kebede, Toadoum Sari Sakayo, Pamela Nyatsine, Freedmore Sidume, Oreen Yousuf, Mardiyyah Oduwole, Kanda Tshinu, Ussen Kimanuka, Thina Diko, Siyanda Nxakama, Sinodos Nigusse, Abdulmejid Johar, Shafie Mohamed, Fuad Mire Hassan, Moges Ahmed Mehamed, Evrard Ngabire, Jules Jules, Ivan Ssenkungu, Pontus Stenetorp. Proceedings of the 13th International Joint Conference on Natural Language Processing and the 3rd Conference of the Asia-Pacific Chapter of the Association for Computational Linguistics (Volume 1: Long Papers). 2023.
- Open Access
- 28 December 2022
- Published by Elsevier in Scientific African
- Vol. 19
Design and prototyping of a robotic hand for sign language using locally-sourced materials
- 28 December 2022
- Published by Elsevier in Scientific African
- Vol. 19
Open AccessDesign and prototyping of a robotic hand for sign language using locally-sourced materials